BioSpace News Archive

Business

Perrigo Announces 2018 Second Quarterly Dividend

Perrigo Company plc announced that its Board of Directors declared a quarterly dividend of $0.19 per share, payable on September 18, 2018 to shareholders of record on August 31, 2018.

August 1, 2018
·
4 min read
Genetown

AdMeTech Foundation Announces the Third Annual Global Summit and Brain Trust on Precision Diagnosis and Treatment of Prostate Cancer

Key International Opinion Leaders Join Efforts to Accelerate Multi-Disciplinary Education and Consensus on Clinical Adoption of the Groundbreaking Best Practices in Patient Care

August 1, 2018
·
3 min read
Business

TSO3 Announces Closing of US$20 million Financing with Courage Capital to Commercialize the STERIZONE® VP4 Sterilizer and Support Getinge Transition

August 1, 2018
·
10 min read
Business

Imaging Endpoints Appoints Manual Ramirez as Chief Compliance and Regulatory Affairs Officer

Growth Driving Opportunities and Expansion

August 1, 2018
·
3 min read
Business

IGM Biosciences Appoints Daniel S. Chen, M.D., Ph.D., as Chief Medical Officer; Names William Strohl, Ph.D., to Board of Directors

Dr. Daniel Chen, Former Global Head of Cancer Immunotherapy Development at Genentech/Roche and Noted Immuno-Oncology Expert, to Lead Company’s Emerging Clinical Development Initiatives

August 1, 2018
·
6 min read
Business

Medical Marijuana, Inc. Portfolio Company Kannalife Sciences Finalizes Share Exchange Agreement with TYG Solutions

Medical Marijuana, Inc. announced that its portfolio company Kannalife Sciences, Inc. has completed a share exchange offer with TYG Solutions Corp.

August 1, 2018
·
4 min read
Biotech Beach

Beckman Coulter Announces Commercialization of DxM MicroScan WalkAway System

System enhancements provide laboratories with gold-standard[1] accuracy to optimize patient care and reduce the risk of emerging antimicrobial resistance

August 1, 2018
·
5 min read
Business

The Prostate Cancer Foundation Appoints Christine Jones As Chief Operating Officer

Christine Jones has been appointed Chief Operating Officer effective immediately reporting to Jonathan W. Simons, MD, President and Chief Executive Officer (CEO)

August 1, 2018
·
3 min read
Policy

Emmaus Life Sciences Announces Support of Sickle Cell Disease Legislation

Bill Aims to Improve Understanding of Health Care System Utilization for Patients with SCD

August 1, 2018
·
4 min read
Drug Development

Clover Biopharmaceuticals Initiates Phase I Study of Etanercept Biosimilar Candidate SCB-808 in China

SCB-808 is a proposed biosimilar of Enbrel® (etanercept) being developed in the prefilled syringe formulation for the treatment of rheumatoid arthritis and other autoimmune diseases.

August 1, 2018
·
2 min read